LICENSE AND DEVELOPMENT AGREEMENTLicense and Development Agreement • February 16th, 2016 • Acura Pharmaceuticals, Inc • Pharmaceutical preparations • New Jersey
Contract Type FiledFebruary 16th, 2016 Company Industry JurisdictionThis License and Development Agreement (“Agreement”) is made and entered into as of this June 5, 2015 (the “Effective Date”) by and between Bayer HealthCare LLC, with offices at 100 Bayer Blvd., Whippany, NJ 07981 (“Bayer”), and Acura Pharmaceuticals, Inc., with offices at 616 N. North Court, Palatine IL 60067 (“Acura”). Bayer and Acura each are referred to herein as a “Party” and collectively as the “Parties.”
LICENSE AND DEVELOPMENT AGREEMENTLicense and Development Agreement • August 3rd, 2015 • Acura Pharmaceuticals, Inc • Pharmaceutical preparations • New Jersey
Contract Type FiledAugust 3rd, 2015 Company Industry JurisdictionThis License and Development Agreement (“Agreement”) is made and entered into as of this June 5, 2015 (the “Effective Date”) by and between Bayer HealthCare LLC, with offices at 100 Bayer Blvd., Whippany, NJ 07981 (“Bayer”), and Acura Pharmaceuticals, Inc., with offices at 616 N. North Court, Palatine IL 60067 (“Acura”). Bayer and Acura each are referred to herein as a “Party” and collectively as the “Parties.”